Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Lymphoma

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 39 articles: HTML format Text format

Single Articles

January 2012
1. ROSE H , Kulik M, Standish R, Prewett E, et al
   Constrictive pericarditis and primary effusion lymphoma following allogeneic BMT for CML.
   Bone Marrow Transplant. 2012 Jan 16. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
2. HUBEL K , Fresen MM, Apperley JF, Basak GW, et al
   European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.
   Bone Marrow Transplant. 2011 Nov 14. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. AHMADI T , McQuade J, Porter D, Frey N, et al
   Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance.
   Bone Marrow Transplant. 2011 Nov 14. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
4. GEORGE B , Benson W, Hertzberg MS
   A pilot study on the use of outpatient fractionated ifosfamide, carboplatin and etoposide (ICE) and pegfilgrastim as a salvage and mobilizing regimen for relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
   Bone Marrow Transplant. 2011 Oct 17. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles   
   
   
   
   
5. REDDY N , Savani BN
   Primary central nervous system lymphoma: implication of high-dose chemotherapy followed by auto-SCT.
   Bone Marrow Transplant. 2011 Oct 17. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
6. HAN EJ , Yang SA, Sohn HS, Kim JI, et al
   Successful treatment with tandem consolidation using (90)yttrium-ibritumomab tiuxetan (Zevalin) and high-dose therapy with autologous PBSCT in a patient with relapsed mantle cell lymphoma presenting as multiple lymphomatous polyposis.
   Bone Marrow Transplant. 2011 Sep 26. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles   
   
   
   
   
7. IANOTTO JC , Tempescul A, Yan X, Delepine P, et al
   Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients.
   Bone Marrow Transplant. 2011 Sep 26. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles   
   
   
   
   August 2011
8. JAGASIA MH , Savani BN, Neff A, Dixon S, et al
   Outcome, toxicity profile and cost analysis of autologous stem cell mobilization.
   Bone Marrow Transplant. 2011;46:1084-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. HUBEL K , Fresen MM, Salwender H, Basara N, et al
   Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program.
   Bone Marrow Transplant. 2011;46:1045-52.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
10. SINHA S , Gastineau D, Micallef I, Hogan W, et al
    Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.
    Bone Marrow Transplant. 2011;46:943-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
11. KIM JE , Yoo C, Kim S, Lee DH, et al
    Optimal timing of G-CSF administration for effective autologous stem cell collection.
    Bone Marrow Transplant. 2011;46:806-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
12. OLIVIERI A , Marchetti M, Lemoli R, Tarella C, et al
    Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo italianoTrapianto di Midollo Osseo.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. WATERMAN J , Rybicki L, Bolwell B, Copelan E, et al
    Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. GUILCHER GM , Rizzuti FA, Lewis VA, Stewart DA, et al
    Single-agent high-dose melphalan followed by auto-SCT for relapsed and refractory Hodgkin lymphoma in children and adolescents.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
15. MAHINDRA A , Bolwell BJ, Rybicki L, Elder P, et al
    Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
16. STOVER DG , Reddy VK, Shyr Y, Savani BN, et al
    Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. JABBOUR M , Tuncer H, Castillo J, Butera J, et al
    Hematopoietic SCT for adult T-cell leukemia/lymphoma: a review.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. JANTUNEN E , Penttila K, Pyorala M, Mahlamaki E, et al
    Addition of plerixafor to a chemotherapy plus G-CSF mobilization in hard-to-mobilize patients.
    Bone Marrow Transplant. 2011;46:308-9.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
19. ABOU-NASSAR KE , Stevenson KE, Antin JH, McDermott K, et al
    (90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. PUIG N , Pintilie M, Seshadri T, Al-Farsi K, et al
    High-dose chemotherapy and ASCT in elderly patients with Hodgkin's lymphoma.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. WOOLTHUIS C , Agool A, Olthof S, Slart RH, et al
    Auto-SCT induces a phenotypic shift from CMP to GMP progenitors, reduces clonogenic potential and enhances in vitro and in vivo cycling activity defined by (18)F-FLT PET scanning.
    Bone Marrow Transplant. 2011;46:110-5.
    PubMed     Text format     Related articles   
    
    
    
    
22. COSTA LJ , Alexander ET, Hogan KR, Schaub C, et al
    Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization.
    Bone Marrow Transplant. 2011;46:64-9.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
23. ANDORSKY DJ , Cohen M, Naeim A, Pinter-Brown L, et al
    Outcomes of auto-SCT for lymphoma in subjects aged 70 years and over.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
24. SYMEONIDIS A , Liga M, Triantafyllou E, Kouraklis A, et al
    Successful mobilization with plerixafor and autologous hematopoietic SCT in a patient with refractory Hodgkin's lymphoma and Gaucher disease.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
25. ITO T , Makishima H, Nakazawa H, Senoo Y, et al
    Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCT.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
26. KATO J , Mori T, Yokoyama K, Tsukada Y, et al
    Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. JOHANSSON JE , Remberger M, Lj Lazarevic V, Hallbook H, et al
    Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. SHAFEY M , Lupichuk SM, Do T, Owen C, et al
    Preferences of patients and physicians concerning treatment options for relapsed follicular lymphoma: a discrete choice experiment.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
29. HOHLOCH K , Zinzani PL, Linkesch W, Jurczak W, et al
    Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after Auto-SCT: an analysis of the international RIT-Network.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
30. PALMER J , Goggins T, Broadwater G, Chao N, et al
    Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. HOLTAN SG , Feldman AL, Knudson RA, Ketterling RP, et al
    Failure of front-line autologous transplant in anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   
    
    
    
    August 2010
32. PLATTEL WJ , Kluin-Nelemans HC, de Bock GH, van Imhoff GW, et al
    Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. AU WY , Lam KK, Leung AY, Liang RH, et al
    Occult autologous haematopoietic regeneration without disease relapse following myeloablative allogeneic haematopoietic SCT for lymphomas.
    Bone Marrow Transplant. 2010;45:1377-8.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
34. EL-MALLAWANY NK , Geller L, Bollard CM, Wistinghausen B, et al
    Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
35. PAULSON K , Lambert P, Bredeson C, Demers A, et al
    Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort.
    Bone Marrow Transplant. 2010;45:1167-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
36. JOHNSEN HE , Geisler C, Juvonen E, Remes K, et al
    Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. REGELINK JC , Tack GJ, Huijgens PC, Mulder CJ, et al
    Disappointing outcome of allogeneic hematopoietic SCT in two EATL patients.
    Bone Marrow Transplant. 2010;45:959-60.
    PubMed     Text format     Related articles   
    
    
    
    December 2009
38. FESLER MJ , Kudva G, Petruska PJ
    Plerixafor and pegylated filgrastim: a case of safe and effective hematopoietic stem cell mobilization.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles   
    
    
    
    October 2009
39. NIMMAGADDA S , Sweiss K, Mahmud N, Park Y, et al
    Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: